Pharmaceuticals

Artificial Tears Segment to Hold Significant Share of Dry Eye Products Market During 2023–2031  According to our latest study on "Dry Eye Products Market Forecast to 2031 – Global Analysis – Product, Dosage Form, Type, and Distribution Channel," the market was valued at US$ 6.95 billion in 2023 and is projected to reach US$ 10.04 billion by 2031. The market is expected to grow at a CAGR of 4.7% by 2031. Factors such as the rising prevale..

Cosmeceutical Segment to Hold Significant Share of Hyperpigmentation Disorder Treatment Market During 2022–2030 According to our latest study on "Hyperpigmentation Disorder Treatment Market Forecast to 2030 – Global Analysis – Treatment Type, Condition, and End User," the market value is expected to reach US$ 11.78 billion by 2030 from US$ 6.68 billion in 2022; the market is estimated to record a CAGR of 7.4% during 2022–2030. The repor..

Orthopedic Disorders Segment to Dominate Canada Enteral Nutrition Market During 2023–2031  According to our new research study on "Canada Enteral Nutrition Market Size and Forecast (2021–2031), Country Share, Trend, and Growth Opportunity Analysis," the market value is expected to surge from CA$ 514.33 million in 2023 to CA$ 817.11 million by 2031; the market is anticipated to record a CAGR of 6.0% from 2023 to 2031. Key factors driving ..

Biodegradable Segment to Lead Dermal Fillers Market Based on Product During 2023–2031 According to our new research study on “Dermal Fillers Market Forecast to 2031 – Global Analysis – by Product, Material, Application, End User, and Geography,” the market was valued at US$ 4.00 billion in 2023 and is projected to reach US$ 7.58 billion by 2031; it is expected to register a CAGR of 8.3% from 2023 to 2031. Key factors driving the market..

Metformin Segment to Hold Significant Share of Polycystic Ovarian Syndrome (PCOS) Treatment Market During 2023–2031 According to our latest study on "Polycystic Ovarian Syndrome (PCOS) Treatment Market Forecast to 2031 – Global Analysis – Product, and Distribution Channel," the market is expected to reach US$ 5.26 billion by 2031 from US$ 3.46 billion in 2023; it is estimated to record a CAGR of 5.4% during 2023–2031. The report emphasi..

Hormone Therapy Segment Contributed Significantly to Prostate Cancer Treatment Market Size in 2022 According to our new research study on "Prostate Cancer Treatment Market Forecast to 2030 – Global Analysis – by Therapy Type, End User, and Geography" the market is expected to grow from US$ 19.07 billion in 2022 to US$ 34.11 billion by 2030; it is anticipated to record a CAGR of 7.5% from 2022 to 2030. The prostate cancer treatment market r..

Nasopulmonary Segment is Anticipated to Hold Largest Share of Transmucosal Drug Delivery Systems Market According to our new research study on "Transmucosal Drug Delivery Systems Market Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis – by System, End User and Geography," the market is expected to grow from US$ 80.21 billion in 2023 to US$ 129.46 billion by 2031; it is estimated to register a CAGR of ..

Anti-Inflammatory Biologics Held Largest Crohn’s Disease Therapeutics Market Share in 2023 According to our new research study on "Crohn’s Disease Therapeutics Market Forecast to 2031 – Global Analysis – by Drug Class, Distribution Channel, and Geography," the market is expected to grow from US$ 9.68 billion in 2023 to US$ 13.33 billion by 2031; it is anticipated to record a CAGR of 4.1% from 2023 to 2031. The report emphasizes the tre..

Topical Drugs Type to Hold Largest Hypopigmentation Disorder Treatment Market Share During 2023–2031 According to our new research study on "Hypopigmentation Disorder Treatment Market Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis," the market value is projected to grow from US$ 4.4 billion in 2023 to US$ 6.7 billion by 2031; the market is anticipated to record a CAGR of 5.41% from 2023 ..

Epithelial Ovarian Cancer Under Type Segment to Bolster Ovarian Cancer Drugs Market Size During 2022–2030 According to our latest study on "Ovarian Cancer Drugs Market Forecast to 2030 – Global Analysis – Type, Drug Class, and Distribution Channel," the market is expected to reach US$ 3.8 billion by 2030 from US$ 2.1 billion in 2022. The market report emphasizes the key factors driving the market and showcases the developments of promin..